Publication:
Pathophysiology, clinical manifestation and management of angioedema-our experience

dc.contributor.authorAleksić, Aleksandra (58361130800)
dc.contributor.authorBogić, Mirjana (18333561400)
dc.contributor.authorTomić-Spirić, Vesna (6603500319)
dc.contributor.authorPerić-Popadić, Aleksandra (6603261722)
dc.contributor.authorVranješ, Dalibor (54892856900)
dc.contributor.authorBosančić, Borut (56610288000)
dc.date.accessioned2025-06-12T19:58:22Z
dc.date.available2025-06-12T19:58:22Z
dc.date.issued2015
dc.description.abstractIntroduction Angioedema is characterized by subcutaneous and/or submucosal swelling usually localized to the lips, eyelids, tongue, oral cavity, larynx and pharynx. Various types of angioedema, caused by different pathophysiologic mechanisms, can have the same or very similar clinical picture and require different diagnostic and therapeutic procedures. The immediate threat to life as a result of rapidly developed edema of the pharynx and larynx with airway obstruction requires endotracheal intubation or emergency tracheotomy. Standard therapy, which includes epinephrine, second-generation antihistamines and steroids, is not effective in the treatment of all types of angioedema. Objective On the basis of the clinical presentation and course of angioedema, this retrospective study was aimed at contributing to a better understanding of the etiopathogenesis of the disease and at helping determine the most effective available treatment modalities. Methods This retrospective study included patients treated under the diagnosis of angioedema of the upper aerodigestive tract between 2000 and 2012 in the Department of Otorhinolaryngology, Clinical Center of Banja Luka. Results A total of 76 subjects were included in the study. The average age was 62.8 years. There were 40 (52.6%) male and 36 (47.4%) female patients. The largest number of patients (44.7%) had type II angioedema. Almost half of the patients or 36 patients (47.4%) were on treatment with an angiotensinconverting enzyme inhibitor (ACEi), but there was no statistically significant difference under the total number of patients (p=0.678). Conclusion Better understanding of pathophysiologic mechanisms and the adoption of diagnostic protocols contributes to more effective treatment of angioedema. © 2015 Serbia Medical Society. All rightsreserved.
dc.identifier.urihttps://doi.org/10.2298/SARH1510545A
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-84946722407&doi=10.2298%2fSARH1510545A&partnerID=40&md5=e7b5137490e4b56704e55fdf6cee22d6
dc.identifier.urihttps://remedy.med.bg.ac.rs/handle/123456789/8443
dc.subjectAngioedema
dc.subjectPathophysiologic mechanisms
dc.subjectTreatment
dc.titlePathophysiology, clinical manifestation and management of angioedema-our experience
dspace.entity.typePublication

Files